Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience
- 29 August 2002
- journal article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 116A (1), 31-36
- https://doi.org/10.1002/ajmg.a.10817
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Pregnancy outcome post renal transplantationTeratology, 2002
- Prednisone and Aspirin in Women with Autoantibodies and Unexplained Recurrent Fetal LossNew England Journal of Medicine, 1997
- IMMUNOSUPPRESSIVE DRUG USE DURING PREGNANCYRheumatic Disease Clinics of North America, 1997
- VARIABLES AFFECTING BIRTHWEIGHT AND GRAFT SURVIVAL IN 197 PREGNANCIES IN CYCLOSPORINE-TREATED FEMALE KIDNEY TRANSPLANT RECIPIENTS1,2Transplantation, 1995
- NATIONAL TRANSPLANTATION PREGNANCY REGISTRY—OUTCOMES OF 154 PREGNANCIES IN CYCLOSPORINE-TREATED FEMALE KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1994
- Mild Errors of Morphogenesis: One of the Most Controversial Subjects in DysmorphologyPublished by Springer Science and Business Media LLC ,1994
- Pregnancy after renal transplantation: 25 years experience in SpainBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- THE OUTCOME OF PREGNANCY FOLLOWING RENAL TRANSPLANTATION—THE EXPERIENCE OF A SINGLE CENTERTransplantation, 1992
- Pregnancy outcome in renal allograft recipients: influence of ciclosporin AEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1991
- Dialysis, Transplantation, and PregnancyAmerican Journal of Kidney Diseases, 1991